Life & Data Science Consulting Swiss Quality
Expert bioinformatics and AI advisory for pharma, biotech,
hospitals, and academic institutions — precision and rigour,
made in Switzerland.
Interactive network
Click · Drag · Explore
About
Kahraman Life and Data Science Consulting is a boutique advisory firm led by Prof. Dr. Abdullah Kahraman — a computational biologist and data scientist with a career spanning the European Bioinformatics Institute at Cambridge, ETH Zurich, the Swiss Institute of Bioinformatics, University Hospital Zurich, University Hospital Basel and FHNW.
We bridge the gap between cutting-edge computational research and the practical realities of clinical and industrial life science settings — bringing world-class scientific rigour and Swiss precision to every engagement.
Services
Driven by demand across pharma, biotech, and hospital networks in the DACH region.
Precision oncology implementation remains unstandardized across DACH institutions. We provide NGS data interpretation, MTPpilot-based visualization, and bioinformatics support to establish and streamline Molecular Tumor Boards at hospitals and cancer centres.
The liquid biopsy market is growing at ~12% CAGR and DACH pharma companies are investing heavily in non-invasive early detection. We develop and validate multimodal algorithms integrating cfDNA, cfRNA, and plasma proteomics for pan-cancer and organ-specific early detection and monitoring.
Swiss and German pharma companies are investing hundreds of millions into AI-driven discovery. We build and validate ML/DL models for biomarker identification, treatment response prediction, and neoantigen pipelines — bridging computational biology with clinical data.
End-to-end design and implementation of NGS analysis pipelines — WGS, WES, RNA-seq, and long-read sequencing. Tumor mutational landscape interpretation, actionable variant identification, and multi-omics integration for research and clinical teams.
Cancer-specific alternative splicing is widely disrupted but underexploited diagnostically. We detect isoform switching events, assess their functional impact via CanIsoNet, and develop splicing-based biomarker signatures for diagnostic and therapeutic applications.
Hospitals and clinical research networks need FHIR-compatible bioinformatics infrastructure to handle increasing NGS panel complexity. We design data platforms, omics databases, and interactive dashboards that integrate into existing hospital IT environments.
Data-driven molecular modelling of protein complexes using AlphaFold and ROSETTA. Integration of cross-linking mass spectrometry data. Structural analysis of isoform-specific interactions in cancer for therapeutic target identification.
Scientific strategy for biotech and pharma R&D programs. Grant proposal writing and review for SNF, Innosuisse, Horizon Europe, and NIH. Technology landscape analysis and scientific advisory board engagement across the DACH region.
Contact
We welcome enquiries from life science companies, hospitals, and academic institutions across Switzerland, Germany, and Austria.
Impressum
Wehntalerstrasse 321
8106 Adlikon bei Regensdorf
Switzerland
The information on this website is provided for general informational purposes only. Despite careful content control, we assume no liability for the content of external links. The operators of linked pages are solely responsible for their content.